Acta Pharmaceutica Sinica B
|
2026, 16(5): 3254-3255
• Correction •
Author correction to “Triterpenoids-templated self-assembly nanosystem for biomimetic delivery of CRISPR/Cas9 based on the synergy of TLR-2 and ICB to enhance HCC immunotherapy” [Acta Pharm Sin B 14 (2024) 3205-3217]
Full
Bing-Chen Zhang1,2, Chun-Mei Lai1, Bang-Yue Luo1, Jing-Wei Shao1,3
Affiliations
1 Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou 350116, China;
2 Department of Laboratory Medicine, Dongguan Institute of Clinical Cancer Research, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Dongguan 523058, China;
3 College of Materials and Chemical Engineering, Minjiang University, Fuzhou 350108, China
doi: 10.1016/j.apsb.2026.03.012
Outline
Bing-Chen Zhang, Chun-Mei Lai, Bang-Yue Luo, Jing-Wei Shao.
Author correction to “Triterpenoids-templated self-assembly nanosystem for biomimetic delivery of CRISPR/Cas9 based on the synergy of TLR-2 and ICB to enhance HCC immunotherapy” [Acta Pharm Sin B 14 (2024) 3205-3217][J].
Acta Pharmaceutica Sinica B,
2026
, 16
(5)
: 3254
-3255
.
DOI: 10.1016/j.apsb.2026.03.012
Year 2026 volume 16 Issue 5
PDF
6
4
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2026.03.012